Emory Genetics Laboratory, Department of Human Genetics, Emory University, Atlanta, GA, USA.
Orphanet J Rare Dis. 2012 Jun 15;7:38. doi: 10.1186/1750-1172-7-38.
Krabbe disease is an autosomal recessive lysosomal storage disorder caused by mutations in the GALC gene. The most common mutation in the Caucasian population is a 30-kb deletion of exons 11 through 17. There are few other reports of intragenic GALC deletions or duplications, due in part to difficulties detecting them.
We used gene-targeted array comparative genomic hybridization (CGH) to analyze the GALC gene in individuals with Krabbe disease in whom sequence analysis with 30-kb deletion analysis identified only one mutation. In our sample of 33 cases, traditional approaches failed to identify two pathogenic mutations in five (15.2%) individuals with confirmed Krabbe disease. The addition of array CGH deletion/duplication analysis to the genetic testing strategy led to the identification of a second pathogenic mutation in three (9.1%) of these five individuals. In all three cases, the deletion or duplication identified through array CGH was a novel GALC mutation, including the only reported duplication in the GALC gene, which would have been missed by traditional testing methodologies. We report these three cases in detail. The second mutation remains unknown in the remaining two individuals (6.1%), despite our full battery of testing.
Analysis of the GALC gene using array CGH deletion/duplication testing increased the two-mutation detection rate from 84.8% to 93.9% in affected individuals. Better mutation detection rates are important for improving molecular diagnosis of Krabbe disease, as well as for providing prenatal and carrier testing in family members.
克拉伯病是一种常染色体隐性溶酶体贮积症,由 GALC 基因突变引起。在白种人群中最常见的突变是 11 号至 17 号外显子的 30kb 缺失。由于检测困难,其他关于基因内 GALC 缺失或重复的报道很少。
我们使用基因靶向阵列比较基因组杂交(CGH)分析了具有克拉伯病的个体的 GALC 基因,这些个体的序列分析显示仅存在 30kb 缺失分析的一个突变。在我们的 33 例病例样本中,传统方法未能在 5 例(15.2%)确诊为克拉伯病的个体中发现两个致病性突变。将阵列 CGH 缺失/重复分析添加到遗传测试策略中,导致在这 5 例个体中的 3 例(9.1%)中确定了第二个致病性突变。在所有 3 例中,通过阵列 CGH 鉴定的缺失或重复是新的 GALC 突变,包括 GALC 基因中唯一报道的重复,这将被传统测试方法遗漏。我们详细报告了这 3 个病例。尽管我们进行了全面的测试,但在其余 2 例个体(6.1%)中,第二个突变仍然未知。
使用阵列 CGH 缺失/重复测试分析 GALC 基因将受影响个体的双突变检测率从 84.8%提高到 93.9%。更好的突变检测率对于改善克拉伯病的分子诊断以及为家庭成员提供产前和携带者检测都很重要。